EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy

Hiroko Nogi, Akiko Ogiya, Makoto Ishitobi, Chikako Yamauchi, Hiroki Mori, Ayaka Shimo, Kazutaka Narui, Naomi Nagura, Hirohito Seki, Shinsuke Sasada, Teruhisa Sakurai, Tadahiko Shien und 1 weitere

Breast Cancer · 2024-05 · 31 (3) · 507-518

DOI: 10.1007/s12282-024-01570-w ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Breast Cancer, online erschienen am 04.04.2024. Verfasst von Hiroko Nogi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Endocrine Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minto-Ku, Tokyo, 105-8461, Japan. nogi_…. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Mammaplasty, Mastectomy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japanese Breast Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In breast cancer patients receiving neoadjuvant chemotherapy (NAC), immediate breast reconstruction (IBR) as a breast cancer treatment option remains controversial. We assessed the impact of NAC on surgical and oncological outcomes of patients undergoing IBR.

Methods

This was a retrospective multicenter study of 4726 breast cancer cases undergoing IBR. The rate of postoperative complications and survival data were compared between IBR patients who received NAC and those who did not receive NAC. Propensity score matching analysis was performed to mitigate selection bias for survival.

Results

Of the total 4726 cases, 473 (10.0%) received NAC. Out of the cases with NAC, 96 (20.3%) experienced postoperative complications, while 744 cases (17.5%) without NAC had postoperative complications. NAC did not significant increase the risk of complications after IBR (Odds ratio, 0.96; 95%CI 0.74–1.25). At the median follow-up time of 76.5 months, 36 patients in the NAC group and 147 patients in the control group developed local recurrences. The 5-year local recurrence-free survival rate was 93.1% in the NAC group and 97.1% in the control group. ( P < 0.001). After matching, there was no significant difference between the two groups.

Conclusion

IBR after NAC is a safe procedure with an acceptable postoperative complication profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoadjuvant TherapyMammaplastyMastectomyPostoperative ComplicationsHumansFemaleMiddle AgedRetrospective StudiesAdultChemotherapy, AdjuvantNeoplasm Recurrence, LocalAgedFollow-Up StudiesTreatment OutcomePropensity ScoreDisease-Free Survival

Stichwörter der Autor:innen

Breast cancerImmediate breast reconstructionLocoregional recurrenceNeoadjuvant chemotherapyPostoperative complications

Autor:innen und Institutionen

  • Department of Breast and Endocrine Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minto-Ku, Tokyo, 105-8461, Japan. nogi_h@jikei.ac.jp.
  • Department of Breast Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Breast Surgery, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Department of Breast Surgery, Mie University School of Medicine, Mie, Japan.
  • Department of Radiation Oncology, Shiga General Hospital, Shiga, Japan.
  • Department of Plastic and Reconstructive Surgery, Tokyo Medical and Dental University, Tokyo, Japan.

Förderung

  • Japanese Breast Cancer Society

Zitieren

APA

Nogi, H., Ogiya, A., Ishitobi, M., Yamauchi, C., Mori, H., Shimo, A., Narui, K., Nagura, N., Seki, H., Sasada, S., Sakurai, T., Shien, T., & Collaborative Study Group of Scientific Research of The Japanese Breast Cancer Society (2024). Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy. Breast Cancer, 31(3), 507-518. https://doi.org/10.1007/s12282-024-01570-w

Vancouver

Nogi H, Ogiya A, Ishitobi M, Yamauchi C, Mori H, Shimo A, et al. Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy. Breast Cancer. 2024;31(3):507-518. doi:10.1007/s12282-024-01570-w

BibTeX
@article{Nogi2024,
  author = {Nogi, Hiroko and Ogiya, Akiko and Ishitobi, Makoto and Yamauchi, Chikako and Mori, Hiroki and Shimo, Ayaka and Narui, Kazutaka and Nagura, Naomi and Seki, Hirohito and Sasada, Shinsuke and Sakurai, Teruhisa and Shien, Tadahiko and Collaborative Study Group of Scientific Research of The Japanese Breast Cancer Society, Collaborative Study Group of Scientific Research of The Japanese Breast Cancer Society},
  title = {Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy},
  journal = {Breast Cancer},
  year = {2024},
  volume = {31},
  number = {3},
  pages = {507--518},
  doi = {10.1007/s12282-024-01570-w}
}
Kostenlos starten →